Fortune Making Indian Pharmaceutical Sector
In this post I tried to let you know about some top rated native companies and analyzed their overall status on global level.
“We look for medicine to be an orderly field of knowledge and procedure. But it is not. It is an imperfect science, an enterprise of constantly changing knowledge, uncertain information, fallible individuals, and at the same time lives on the line. There is science in what we do, yes, but also habit, intuition, and sometimes plain old guessing. The gap between what we know and what we aim for persists. And this gap complicates everything we do.”
Pharmaceutical industry is the most enterprising sector under life sciences growing in leaps and bounds to meet our never ending demands. With the hike in population, globalization, origin of so many lifestyle diseases such as diabetes, cardiovascular diseases and cancer the need for this industry is very pertinent in every country. India’s substantial scientific manpower could be greatly involved in pharma product development steering this sector to an even better position. Here, we shall get to know how well India’s pharmaceutical industry stands out in current scenario.
The pharmaceutical sector of India with an overall market size of about US$20 billion stands as the third largest in volume and in 13th position by value. A report from industry chamber CII shows that Indian pharma industry holds 169 US approved plants and 153 European directorate for quality approved manufacturing units out of which 23% are bulk drug manufacturers and 77% are formulation manufacturers.
Indian life-sciences sector encompassing bioinformatics, bio-pharmaceuticals, bio-agriculture, bio-industry and bioservices is expected to reach US$100 billion by 2025, amongst which biopharma, the largest sub-sector would contribute 62% of the total revenues. India supplies 20% of world’s generic medicines making it the largest supplier which puts us further ahead in the curve.
TOP RATED NATIVE COMPANIES
India’s largest and world’s fifth largest company established in over 150 countries all over the world. It possesses a market value of about ₹196,255.57 crore. They manufacture pharmaceutical products related to diabetics, neurology, cardiology, gastroenterology and orthopedics.
The second largest company offering about 5500 pharma products with a market capitalization of ₹72,461.29 crore. Its recent acquisition of Gavis Pharma has broadened its chance in US generic market.
This company is well known for its rapid growth within a short span of time. It is a 32 year old company producing about 200 products, holding a market value of ₹52,788.76 crore and operating in 20 countries around the world. Recently, it has boosted itself by acquiring FDA approval to launch Aloxi generic.
Positioned as the fourth largest company in India, operating in more than 150 countries, owning more than 30 manufacturing units throughout India, Cipla assures setting up steady footsteps in the global market. It has a market capitalization of ₹43,142.58 crore.
Since being established in 1986 and starting operations in Pondicherry this company has portrayed stunning growth in global market. Currently it owns about 6 manufacturing units and has a market value of ₹44,530.79 crore.
These giants in manufacturing sector ensure us of making India top the global market in upcoming future. However, proper channelizing and wise strategies will be of great use to withstand the competition and pressure acting against the growth and development of this sector.
Featured Image: Three-dimensional Image Of The Golden Symbol Of The Indian Rupee Among Colored Rays© nik_gru (Stock Photo ID: 90137519)